
What We’re Reading: HHS to Expand Nursing Home Ownership Info; Unprotected Mental Health Data; FDA Rebuffs Cancer Drug
HHS wants to require nursing homes to disclose more ownership and management information; privacy advocates warn that mental health data can legally be sold from certain platforms not covered by the Health Insurance Portability and Accountability Act; the FDA won’t review Soligenix’s cancer drug proposal because of an insufficient application.
HHS Aims to Require Nursing Home Ownership Transparency
A new rule requiring nursing homes to offer more information on their ownership and management is being proposed by HHS,
Sale of Mental Health Data Unprotected by Law
Data provided to telehealth and therapy apps are being sold by data brokers legally and without knowledge or consent,
FDA Won’t Review Soligenix’s Cancer Drug
On Tuesday, Soligenix said that its cancer drug proposal application won’t be reviewed by the FDA, which said it was incomplete,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.